Canada Markets closed

Iterum Therapeutics plc (ITRM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.2002-0.0209 (-9.45%)
At close: 04:00PM EDT
0.2085 +0.01 (+4.15%)
After hours: 05:03PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.07
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 32.3600
52 Week Low 30.1750
50-Day Moving Average 30.2348
200-Day Moving Average 30.3982

Share Statistics

Avg Vol (3 month) 31.14M
Avg Vol (10 day) 31.6M
Shares Outstanding 5182.78M
Implied Shares Outstanding 6N/A
Float 8181.77M
% Held by Insiders 10.76%
% Held by Institutions 13.65%
Shares Short (Apr 28, 2022) 44.18M
Short Ratio (Apr 28, 2022) 44.02
Short % of Float (Apr 28, 2022) 42.31%
Short % of Shares Outstanding (Apr 28, 2022) 42.28%
Shares Short (prior month Mar 30, 2022) 43.55M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-24.67%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -22.43M
Net Income Avi to Common (ttm)-91.56M
Diluted EPS (ttm)-0.7690
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)81.38M
Total Cash Per Share (mrq)0.44
Total Debt (mrq)30.43M
Total Debt/Equity (mrq)60.57
Current Ratio (mrq)6.43
Book Value Per Share (mrq)0.29

Cash Flow Statement

Operating Cash Flow (ttm)-15.84M
Levered Free Cash Flow (ttm)-28.78M